Learn the significance and the key themes of China's upcoming Third Plenum and our intelligence service to help foreign businesses keep up with its latest development.
For as long as they have operated in the public eye, private equity firms have faced reputational issues. But through strategic communications, PE firms can build more positive relationships with key stakeholders, and position the industry as a force for good.
The contrasting trends and gaps between mature and emerging healthcare markets in the Asia Pacific and the Middle East regions present numerous opportunities. Healthcare organisations should monitor these trends closely, leveraging the opportunities to drive growth and improve healthcare outcomes.
As we mark World Environment Day 2024, it's clear that our generation holds the responsibility and the power to restore our planet. Strategic communication plays a pivotal role in rallying stakeholders and accelerating progress.
As trust in the tech industry has dropped to an all-time low, tech companies must communicate their vision and purpose more than ever to regain trust in their brands.
Respiratory illnesses continue to surge globally following the COVID-19 pandemic, posing a growing challenge to the healthcare systems, especially in the Asia-Pacific region.
Recently China has made some impressive advances in carbon capture, utilisation, and storage (CCUS). However, like many other cutting-edge green technologies, there are significant challenges at play.
China’s reopening may well be the most consequential economic event of 2023 with significant impact on global supply chain, tourism, foreign investment, and commodity prices expected.
A brief introduction to China’s leadership structure for those who are interested in tracking China's policy development and its economic implications.
Given China's size, economic growth and influence, it’s imperative for financial firms to have a customised PR strategy for the Chinese market to be successful.
Under China's new medical reform, the government has become the largest purchaser of medicine. For pharmaceutical enterprises, favourable policies are the key to market access.